Literature DB >> 17533491

High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening.

Harriet Stenvall1, Ingrid Wikström, Erik Wilander.   

Abstract

Since the introduction of organized cytological screening in Sweden, most women currently presenting with cervical cancer are those who have not attended the programme and who have no cytological screening history. The aims of this study were: (i) to measure the response rate among women not attending organized cytological screening who were offered a device for self-sampling a vaginal smear at home; (ii) to examine the prevalence of high-risk human papilloma virus (HPV) among women performing self-sampling. Women aged 35-50 years, who had not participated in organized cytological screening for more than 6 years, were offered the opportunity to collect vaginal samples at home using a self-sampling device (Qvintip). The material collected was analysed for high-risk HPV using the Hybrid Capture 2 method. Of 369 women included in the study, 179 (49%) ordered the self-sampling device and 117 (32%) performed self-sampling at home and sent the sample to our laboratory for analysis. The mean prevalence of high-risk HPV was 26% (30/117), 31% (25/80) in women aged 35-42 years and 14% (5/37) in women aged 43-50 years. There was no significant difference in the participation rate with regard to age. The prevalence of high-risk HPV in women not covered by organized screening was considerably higher than in the general population; therefore they may represent a category at high risk of cervical cancer. The study shows that the use of a disposable self-sampling device for HPV testing is a relevant method to increase the participation rate in countries with organized cytological screening.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533491     DOI: 10.2340/00015555-0205

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  11 in total

1.  Strategies for Increasing Cervical Cancer Screening Amongst First Nations Communities in Northwest Ontario, Canada.

Authors:  Marion Maar; Pamela Wakewich; Brianne Wood; Alberto Severini; Julian Little; Ann N Burchell; Gina Ogilvie; Ingeborg Zehbe
Journal:  Health Care Women Int       Date:  2014-11-24

2.  Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling.

Authors:  Anna-Barbara Moscicki; Lea Widdice; Yifei Ma; Sepideh Farhat; Susanna Miller-Benningfield; Janet Jonte; Julie Jay; Cheryl Godwin de Medina; Evelyn Hanson; Lisa Clayton; Stephen Shiboski
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

3.  Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study.

Authors:  Ingeborg Zehbe; Helle Moeller; Alberto Severini; Bruce Weaver; Nicholas Escott; Crystal Bell; Sandra Crawford; Diane Bannon; Natalie Paavola
Journal:  BMJ Open       Date:  2011-02-26       Impact factor: 2.692

4.  Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in GP primary care.

Authors:  Anita Wey Wey Lim; Peter Sasieni
Journal:  J Med Screen       Date:  2015-03-05       Impact factor: 2.136

5.  Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.

Authors:  Ingeborg Zehbe; Robert Jackson; Brianne Wood; Bruce Weaver; Nicholas Escott; Alberto Severini; Mel Krajden; Lisa Bishop; Kyla Morrisseau; Gina Ogilvie; Ann N Burchell; Julian Little
Journal:  BMJ Open       Date:  2016-10-08       Impact factor: 2.692

6.  Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.

Authors:  Janni Uyen Hoa Lam; Matejka Rebolj; Ditte Møller Ejegod; Helle Pedersen; Carsten Rygaard; Elsebeth Lynge; Louise Thirstrup Thomsen; Susanne Krüger Kjaer; Jesper Bonde
Journal:  Int J Cancer       Date:  2017-02-27       Impact factor: 7.396

7.  Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.

Authors:  Inger Gustavsson; Riina Aarnio; Malin Berggrund; Julia Hedlund-Lindberg; Ann-Sofi Strand; Karin Sanner; Ingrid Wikström; Stefan Enroth; Matts Olovsson; Ulf Gyllensten
Journal:  Br J Cancer       Date:  2018-02-13       Impact factor: 7.640

8.  Self-sampling of the vaginal fluid at home combined with high-risk HPV testing.

Authors:  K Sanner; I Wikström; A Strand; M Lindell; E Wilander
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

9.  Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.

Authors:  J U H Lam; M Rebolj; D M Ejegod; H Pedersen; C Rygaard; E Lynge; E Harder; L T Thomsen; S K Kjaer; J Bonde
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

10.  Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection.

Authors:  Avalon Ernstson; Annika Urdell; Ola Forslund; Christer Borgfeldt
Journal:  Infect Agent Cancer       Date:  2020-02-13       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.